Transmedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. The company offers its products in the United States and internationally. Transmedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.
Market Cap | 875.209 Million | Shares Outstanding | 27.962 Million | Avg 30-day Volume | 214.723 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.68 |
Price to Revenue | 17.4852 | Debt to Equity | 0.5187 | EBITDA | -37.132 Million |
Price to Book Value | 7.7982 | Operating Margin | -130.2888 | Enterprise Value | 471.884 Million |
Current Ratio | 5.108 | EPS Growth | -0.379 | Quick Ratio | 4.234 |
1 Yr BETA | 2.21 | 52-week High/Low | 35.37 / 10.0 | Profit Margin | -146.1073 |
Operating Cash Flow Growth | 4.6291 | Altman Z-Score | 0.2314 | Free Cash Flow to Firm | -25.293 Million |
Earnings Report | 2022-08-04 |
Please sign in first
none
51.5 Thousand total shares from 4 transactions
3 Thousand total shares from 2 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
13,500 | 2022-06-01 | 1 | |
|
13,500 | 2022-06-01 | 3 | |
|
13,500 | 2022-06-01 | 3 | |
|
13,500 | 2022-06-01 | 1 | |
|
13,500 | 2022-06-01 | 1 | |
|
13,500 | 2022-06-01 | 1 | |
|
13,500 | 2022-06-01 | 1 | |
CAREY JOHN F VP OF OPERATIONS |
|
23,868 | 2022-06-01 | 10 |
KHAYAL TAMER I CHIEF COMMERCIAL OFFICER |
|
52,000 | 2022-02-22 | 3 |
HASSANEIN WALEED H PRESIDENT & CEO |
|
250,000 | 2022-02-22 | 2 |
PROVOST MIRIAM VP OF GLOBAL REGL. AFFAIRS |
|
38,000 | 2022-02-22 | 4 |
GORDON STEPHEN CHIEF FINANCIAL OFFICER |
|
52,000 | 2022-02-22 | 3 |
DAMME LAURA VP, CLINICAL AFFAIRS |
|
38,000 | 2022-02-22 | 1 |
SULLIVAN JOHN F VP OF QUALITY & ENGINEERING |
|
30,045 | 2021-08-30 | 1 |
GODHANI RAKESH P. CHIEF DIGITAL OFFICER |
|
0 | 2021-08-04 | 2 |
ABRAMS CAPITAL MANAGEMENT, L.P. ABRAMS CAPITAL MANAGEMENT, LLC ABRAMS CAPITAL PARTNERS II, L.P. |
|
No longer subject to file | 2021-02-08 | 0 |
|
No longer subject to file | 2019-12-09 | 0 | |
FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC FLAGSHIP VENTURES FUND IV, L.P. FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC |
|
No longer subject to file | 2019-10-29 | 0 |
|
0 | 2019-05-01 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-06-03 17:00:25 -0400 | 2022-06-01 | M | 1,500 | $0.28 | a | 1,879 | direct | yes | 1.9608 | -6.5723 | 1.9608 | 2 | -6.5723 | 6 | ||
2022-06-03 17:00:25 -0400 | 2022-06-01 | S | 978 | $27.89 | d | 901 | direct | yes | 1.9608 | -6.5723 | 1.9608 | 2 | -6.5723 | 6 | ||
2022-06-03 17:00:25 -0400 | 2022-06-01 | S | 522 | $28.74 | d | 379 | direct | yes | 1.9608 | -6.5723 | 1.9608 | 2 | -6.5723 | 6 | ||
2022-06-03 17:00:25 -0400 | 2022-06-01 | M | 1,500 | d | 23,489 | direct | yes | |||||||||
2022-06-06 16:28:41 -0400 | 2022-06-01 | A | 13,500 | a | 13,500 | direct | ||||||||||
2022-06-06 16:28:13 -0400 | 2022-06-01 | A | 13,500 | a | 13,500 | direct | ||||||||||
2022-06-06 16:29:13 -0400 | 2022-06-01 | A | 13,500 | a | 13,500 | direct | ||||||||||
2022-06-06 16:29:10 -0400 | 2022-06-01 | A | 13,500 | a | 13,500 | direct | ||||||||||
2022-06-06 16:32:42 -0400 | 2022-06-01 | A | 13,500 | a | 13,500 | direct | ||||||||||
2022-06-06 16:32:37 -0400 | 2022-06-01 | A | 13,500 | a | 13,500 | direct | ||||||||||
2022-06-06 16:33:44 -0400 | 2022-06-01 | A | 13,500 | a | 13,500 | direct | ||||||||||
2022-05-06 16:05:14 -0400 | 2022-05-04 | M | 1,500 | $0.28 | a | 1,879 | direct | yes | -6.9131 | 1.8484 | 7.1349 | 10.4991 | 15 | -8.7246 | 3 | |
2022-05-06 16:05:14 -0400 | 2022-05-04 | S | 1,500 | $25.31 | d | 379 | direct | yes | -6.9131 | 1.8484 | 7.1349 | 10.4991 | 15 | -8.7246 | 3 | |
2022-05-06 16:05:14 -0400 | 2022-05-04 | M | 1,500 | d | 24,989 | direct | yes | |||||||||
TOBIN JAMES R - Director by the james r. tobin 2012 trust |
2022-05-06 16:05:50 -0400 | 2022-05-04 | S | 48,516 | $29.94 | d | 350,621 | indirect | yes | -6.9131 | 1.8484 | 7.1349 | 10.4991 | 15 | -8.7246 | 3 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
TRANSMEDICS GROUP INC TMDX | 2022-06-24 22:15:03 UTC | 0.7373 | 0.8327 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 21:45:03 UTC | 0.7373 | 0.8327 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 21:15:04 UTC | 0.7373 | 0.8327 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 20:45:03 UTC | 0.722 | 0.848 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 20:15:03 UTC | 0.722 | 0.848 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 19:45:03 UTC | 0.722 | 0.848 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 19:15:03 UTC | 0.722 | 0.848 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 18:45:03 UTC | 0.722 | 0.848 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 18:15:04 UTC | 0.722 | 0.848 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 17:45:03 UTC | 0.722 | 0.848 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 17:15:03 UTC | 0.722 | 0.848 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 16:45:03 UTC | 0.722 | 0.848 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 16:15:03 UTC | 0.722 | 0.848 | 450000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 15:45:03 UTC | 0.722 | 0.848 | 400000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 15:15:03 UTC | 0.722 | 0.848 | 400000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 14:45:03 UTC | 0.6695 | 0.9005 | 400000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 14:15:03 UTC | 0.6695 | 0.9005 | 400000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 13:45:03 UTC | 0.6695 | 0.9005 | 400000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 13:15:03 UTC | 0.6695 | 0.9005 | 400000 |
TRANSMEDICS GROUP INC TMDX | 2022-06-24 12:45:03 UTC | 0.6695 | 0.9005 | 400000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund | TMDX | -800.0 shares, $-26544.0 | 2021-06-30 | N-PORT |